SCL Science Inc. (KOSDAQ:246960)

Silk Road Medical Revenue

SCL Science had revenue of 2.27B KRW in the quarter ending March 31, 2025, with 100.03% growth. This brings the company's revenue in the last twelve months to 5.87B, up 158.70% year-over-year. In the year 2024, SCL Science had annual revenue of 4.74B with 258.30% growth.

• Revenue (ttm): 5.87B
• Revenue Growth: +158.70%
• P/S Ratio: 15.19
• Revenue / Employee: 94.69M
• Employees: 62
• Market Cap: 89.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.74B	3.42B	258.30%
Dec 31, 2023	1.32B	952.33M	257.54%
Dec 31, 2022	369.78M	-137.51M	-27.11%
Dec 31, 2021	507.29M	-88.90M	-14.91%
Dec 31, 2020	596.19M	-96.57M	-13.94%